Hydroxychloroquine does not counter SARS-CoV-2 in hamsters, high dose of favipiravir does: study

Date: October 9, 2020 Source 1: KU Leuven Source 2: www.sciencedaily.com Summary: Virologists have shown that a treatment with the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters. A high dose of the anti-flu drug favipiravir, by Read More …